Vol 6, No 8 (April 26, 2018): Annals of Translational Medicine (Focus on “Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation”)

Preface on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation1

Lung cancer: biology and technology foster therapeutic innovation
Giannis Mountzios
Annals of Translational Medicine  
2018;
6
(8)
:137
.

Review Article on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation1

The emerging treatment landscape of advanced non-small cell lung cancer
Panagiota Economopoulou, Giannis Mountzios
Annals of Translational Medicine  
2018;
6
(8)
:138
.
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?
Panagiotis Baxevanos, Giannis Mountzios
Annals of Translational Medicine  
2018;
6
(8)
:139
.
Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)
Giannis Mountzios
Annals of Translational Medicine  
2018;
6
(8)
:140
.
Treating ALK-positive non-small cell lung cancer
Dimitrios C. Ziogas, Anna Tsiara, Georgios Tsironis, Maria Lykka, Michalis Liontos, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Annals of Translational Medicine  
2018;
6
(8)
:141
.
Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
Stavros Gkolfinopoulos, Giannis Mountzios
Annals of Translational Medicine  
2018;
6
(8)
:142
.
Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?
Georgios Tsironis, Dimitrios C. Ziogas, Anastasios Kyriazoglou, Marita Lykka, Konstantinos Koutsoukos, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Annals of Translational Medicine  
2018;
6
(8)
:143
.
Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
Anna Tsiara, Michalis Liontos, Maria Kaparelou, Roubini Zakopoulou, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Annals of Translational Medicine  
2018;
6
(8)
:144
.
Advanced small cell lung cancer (SCLC): new challenges and new expectations
Nikolaos Tsoukalas, Eleni Aravantinou-Fatorou, Panagiotis Baxevanos, Maria Tolia, Konstantinos Tsapakidis, Michail Galanopoulos, Michail Liontos, George Kyrgias
Annals of Translational Medicine  
2018;
6
(8)
:145
.
Advances on systemic treatment for lung neuroendocrine neoplasms
Nikolaos Tsoukalas, Panagiotis Baxevanos, Eleni Aravantinou-Fatorou, Maria Tolia, Michail Galanopoulos, Konstantinos Tsapakidis, George Kyrgias, Christos Toumpanakis, Gregory Kaltsas
Annals of Translational Medicine  
2018;
6
(8)
:146
.

Original Article

Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders
Wilbert S. Aronow, Tatyana A. Shamliyan
Annals of Translational Medicine  
2018;
6
(8)
:147
.
Alcohol use disorders before and after bariatric surgery: a systematic review and meta-analysis
Hamza Azam, Sara Shahrestani, Kevin Phan
Annals of Translational Medicine  
2018;
6
(8)
:148
.
Targets without tolerances: improper evaluation of medical personnel
Robert S. Butler, Douglas Johnston, Michael W. Kattan
Annals of Translational Medicine  
2018;
6
(8)
:149
.
A technique of hand digit reconstruction using scarred and deformed donor segments
Nikolay M. Alexandrov, Michail G. Volovik, Denis V. Kiselev, Sergey V. Petrov
Annals of Translational Medicine  
2018;
6
(8)
:150
.
The practical benefit of Phadiatop test as the first-line in vitro allergen-specific immunoglobulin E (sIgE) screening of aeroallergens among Chinese asthmatics: a validation study
Guangqiao Zeng, Haisheng Hu, Peiyan Zheng, Ge Wu, Nili Wei, Xueqing Liang, Baoqing Sun, Xiaowen Zhang
Annals of Translational Medicine  
2018;
6
(8)
:151
.
Rosiglitazone inhibits PM2.5-induced cytotoxicity in human lung epithelial A549 cells
Xian-Juan Pu, Jin Li, Qiu-Lian Zhou, Wen Pan, Yong-Qin Li, Yuhui Zhang, Jinhua Wang, Zheng Jiao
Annals of Translational Medicine  
2018;
6
(8)
:152
.
Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α
Rong-Rong Gao, Xiao-Dong Wu, Hui-Min Jiang, Yu-Jiao Zhu, Yan-Li Zhou, Hai-Feng Zhang, Wen-Ming Yao, Yong-Qin Li, Xin-Li Li
Annals of Translational Medicine  
2018;
6
(8)
:153
.

Review Article

Aminoquinoline antimalarial therapy in dermatomyositis—are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity?
Richard D. Sontheimer
Annals of Translational Medicine  
2018;
6
(8)
:154
.
Immune checkpoint inhibitors and radiotherapy—concept and review of current literature
Loka Thangamathesvaran, Roshni Shah, Rebeka Verma, Omar Mahmoud
Annals of Translational Medicine  
2018;
6
(8)
:155
.

Case Report

Abnormal chest X-ray leading to diagnosis of partial anomalous pulmonary venous connection
Zahava Farkas, Abbas Haidry, Srikanth Yandrapalli, Marc Lim, Diwakar Jain, Wilbert S. Aronow
Annals of Translational Medicine  
2018;
6
(8)
:156
.

Disclosure:

1. The series “Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Giannis Mountzios served as the unpaid Guest Editor for the series.